AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2021 Issue 4; ICD-10-CM New/Revised Codes
Complications of Immune Effector Cellular Therapy
A new code has been created to capture complications of immune effector cellular (IEC) therapy with the corresponding seventh characters for initial encounter, subsequent encounter and sequela as follows: T80.82, Complication of immune effector cellular therapy Immune effector cells have the ability to modulate or effect an immune response. B cells, dendritic cells, natural killer cells, and T cells are collected from the patient, transformed into a therapeutic product, and then administered back into the patient. These cellular therapy products are part of an innovative cancer treatment called immunotherapy, in which the patient’s immune system attacks the...
Subscribe or sign in to view the full article.
Article Overview
This article covers a new ICD-10-CM diagnosis code created for complications of immune effector cellular therapy, along with the related context of immunotherapy toxicities and outcome tracking. It is relevant for coders, clinical documentation staff, and oncology teams who need to understand the scope of the new reporting category and the broader complication landscape associated with this therapy type.
Why This Topic Matters
The article matters because it highlights a new diagnosis coding option tied to emerging cancer therapies and explains the associated complication reporting context. It is useful for organizations that are tracking therapy-related toxicities, documentation trends, and coding updates in oncology settings.
What You Will Learn
- What clinical area the new diagnosis code relates to
- How immune effector cellular therapy is described in the article
- Which complication categories are discussed in the context of therapy toxicity
- Why the new coding category is relevant for documentation and data tracking
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation specialists
- Oncology clinicians
- Healthcare data analysts
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com